MAPK14 and osteoarthritis: The third compound was dilmapimod, a p38 mitogen-activated protein kinase (MAPK) inhibitor with known anti-inflammatory effects36; the fourth was glucosamine, which has been used in cases with osteoarthritis; while the fifth was VX-702, another p38 MAPK inhibitor.